Universities, Governments & Accelerators
Grants fund science.
Operators build companies.
Universities, government agencies & accelerator programs
Your institution invests in breakthrough research, promising cohorts, and ambitious grant programs — yet most of that potential stalls at the commercialization gap. Closing it takes embedded operators who have built companies from early-stage science and can deliver measurable outcomes across an entire portfolio.
The Precision Advantage
Why institutions choose us.
Our operators have supported hundreds of launches, raised billions in capital, and driven 50+ successful exits — partnering with universities, government programs, and accelerators.
Built for Institutional Scale
We support entire portfolios, not just individual ventures. Our model scales across your cohort, pipeline, or grant portfolio with institutional-grade reporting.
Operators, Not Consultants
Every team member has held the C-suite role they advise on — from regulatory submissions to commercial launches to successful exits.
Measurable Program Outcomes
We structure engagements around the metrics that matter to your stakeholders — successful spinouts, capital raised, products launched, and jobs created.
Lab to Market, End to End
Regulatory, reimbursement, commercial, capital strategy — every capability a spinout needs, deployed under one roof by people who have done it before.
Expertise in Action
How we strengthen your innovation ecosystem.
Portfolio Commercialization Strategy
Technology assessment, market sizing, competitive landscaping, and pathway prioritization across your entire IP portfolio — identifying the ventures with the highest commercial potential.
Spinout Formation & Launch Support
Entity structuring, licensing frameworks, founder equity design, board composition, governance setup, and operational buildout for university and government-funded spinouts.
Grant Program Design & Administration
SBIR, STTR, NIH, NSF, and DOD grant program design, milestone frameworks, award management, and portfolio-level outcome tracking for institutional funders.
Regulatory & Clinical Strategy
510(k), De Novo, PMA, and Breakthrough Device pathway guidance for portfolio companies. Pre-submission strategy and end-to-end clinical trial design.
Accelerator & Incubator Program Design
Curriculum design, cohort mentorship, milestone-based programming, demo day preparation, and venture development infrastructure for institutional programs.
Investor Readiness & Capital Formation
Portfolio-wide pitch preparation, financial modeling, data room creation, investor introductions, and phased capital strategy for institutional spinouts.
Fractional C-Suite for Portfolio Companies
Deploy experienced executives across your portfolio — CEO, CFO, CCO, Regulatory — at fractional cost with institutional accountability and reporting.
Public-Private Partnership Development
Government contracting frameworks, interagency collaboration, public-private partnership structuring, economic impact reporting, and policy-aligned commercialization strategy.
Your Next Move
Stronger programs. More successful ventures.
Let’s turn your pipeline into companies.